Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice

Glucagon-like peptide-1 ameliorates the symptoms of diabetes through stimulation of insulin secretion and enhancement of beta-cell mass. We have therefore investigated the effects of glucagon-like peptide-1 on the development of diabetes, using db/db mice as a model of Type II diabetes. The potent g...

Ausführliche Beschreibung